$RMD
RESMED INC

2020 Q3 Form 10-Q Financial Statement

#000094381920000024 Filed on October 30, 2020

View on sec.gov

Income Statement

Concept 2020 Q3 2019 Q3
Revenue $751.9M $681.1M
YoY Change 10.4% 15.77%
Cost Of Revenue $313.3M $289.4M
YoY Change 8.24% 18.05%
Gross Profit $438.7M $391.6M
YoY Change 12.01% 14.14%
Gross Profit Margin 58.34% 57.5%
Selling, General & Admin $159.0M $167.4M
YoY Change -5.05% 13.67%
% of Gross Profit 36.24% 42.76%
Research & Development $54.53M $48.03M
YoY Change 13.53% 23.83%
% of Gross Profit 12.43% 12.27%
Depreciation & Amortization $39.47M $37.95M
YoY Change 3.98% 24.75%
% of Gross Profit 9.0% 9.69%
Operating Expenses $221.8M $220.5M
YoY Change 0.57% 10.83%
Operating Profit $216.9M $171.1M
YoY Change 26.76% 18.71%
Interest Expense $6.725M $10.99M
YoY Change -38.82% 196.44%
% of Operating Profit 3.1% 6.42%
Other Income/Expense, Net -$1.042M -$20.52M
YoY Change -94.92% 290.69%
Pretax Income $215.9M $150.6M
YoY Change 43.34% 8.43%
Income Tax $37.48M $30.44M
% Of Pretax Income 17.36% 20.21%
Net Earnings $178.4M $120.1M
YoY Change 48.46% 13.63%
Net Earnings / Revenue 23.72% 17.64%
Basic Earnings Per Share $1.23 $0.84
Diluted Earnings Per Share $1.22 $0.83
COMMON SHARES
Basic Shares Outstanding 144.9M 143.7M
Diluted Shares Outstanding 146.1M 145.1M

Balance Sheet

Concept 2020 Q3 2019 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $421.4M $172.2M
YoY Change 144.72% -25.2%
Cash & Equivalents $421.4M $172.2M
Short-Term Investments
Other Short-Term Assets $168.7M $129.5M
YoY Change 30.27% 30.94%
Inventory $478.0M $357.0M
Prepaid Expenses
Receivables $464.9M $493.8M
Other Receivables $0.00 $0.00
Total Short-Term Assets $1.543B $1.161B
YoY Change 32.86% 6.69%
LONG-TERM ASSETS
Property, Plant & Equipment $424.8M $383.0M
YoY Change 10.93% 0.3%
Goodwill $1.900B $1.856B
YoY Change 2.33% 55.74%
Intangibles
YoY Change
Long-Term Investments $18.07M $45.40M
YoY Change -60.2% 8.14%
Other Assets $145.5M $141.3M
YoY Change 2.96% 20.77%
Total Long-Term Assets $3.078B $2.993B
YoY Change 2.83% 51.24%
TOTAL ASSETS
Total Short-Term Assets $1.543B $1.161B
Total Long-Term Assets $3.078B $2.993B
Total Assets $4.621B $4.155B
YoY Change 11.22% 35.44%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $117.6M $109.7M
YoY Change 7.15% 11.18%
Accrued Expenses $269.9M $231.3M
YoY Change 16.69% 36.46%
Deferred Revenue $102.0M $86.95M
YoY Change 17.34% 34.14%
Short-Term Debt $11.99M $11.99M
YoY Change -0.03% 0.14%
Long-Term Debt Due $12.00M $12.00M
YoY Change 0.0% 0.0%
Total Short-Term Liabilities $590.9M $550.5M
YoY Change 7.34% 30.72%
LONG-TERM LIABILITIES
Long-Term Debt $1.044B $1.208B
YoY Change -13.56% 133.42%
Other Long-Term Liabilities $8.568M $2.047M
YoY Change 318.56% 283.33%
Total Long-Term Liabilities $1.351B $1.487B
YoY Change -9.13% 99.26%
TOTAL LIABILITIES
Total Short-Term Liabilities $590.9M $550.5M
Total Long-Term Liabilities $1.351B $1.487B
Total Liabilities $1.942B $2.037B
YoY Change -4.68% 74.53%
SHAREHOLDERS EQUITY
Retained Earnings $2.954B $2.501B
YoY Change 18.12% 8.88%
Common Stock $1.588B $1.530B
YoY Change 3.79% 4.53%
Preferred Stock
YoY Change
Treasury Stock (at cost) $1.623B $1.623B
YoY Change 0.0% 0.0%
Treasury Stock Shares $41.84M $41.84M
Shareholders Equity $2.679B $2.117B
YoY Change
Total Liabilities & Shareholders Equity $4.621B $4.155B
YoY Change 11.22% 35.44%

Cashflow Statement

Concept 2020 Q3 2019 Q3
OPERATING ACTIVITIES
Net Income $178.4M $120.1M
YoY Change 48.46% 13.63%
Depreciation, Depletion And Amortization $39.47M $37.95M
YoY Change 3.98% 24.75%
Cash From Operating Activities $144.0M $162.4M
YoY Change -11.31% 237.42%
INVESTING ACTIVITIES
Capital Expenditures $13.50M $22.67M
YoY Change -40.45% 74.47%
Acquisitions
YoY Change
Other Investing Activities -$3.400M -$8.500M
YoY Change -60.0% -93.59%
Cash From Investing Activities -$22.11M -$33.22M
YoY Change -33.45% -77.58%
FINANCING ACTIVITIES
Cash Dividend Paid $56.51M $56.05M
YoY Change 0.82% 6.17%
Common Stock Issuance & Retirement, Net $1.026M $5.609M
YoY Change -81.71% -70.3%
Debt Paid & Issued, Net $175.0M $614.0M
YoY Change -71.5% 612.85%
Cash From Financing Activities -175.3M -100.1M
YoY Change 75.13% -169.1%
NET CHANGE
Cash From Operating Activities 144.0M 162.4M
Cash From Investing Activities -22.11M -33.22M
Cash From Financing Activities -175.3M -100.1M
Net Change In Cash -41.74M 25.03M
YoY Change -266.79% -39.68%
FREE CASH FLOW
Cash From Operating Activities $144.0M $162.4M
Capital Expenditures $13.50M $22.67M
Free Cash Flow $130.5M $139.7M
YoY Change -6.58% 297.7%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q3 dei Amendment Flag
AmendmentFlag
false
CY2020Q3 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
CY2020Q3 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2020Q3 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2020Q3 dei Entity Address Country
EntityAddressCountry
US
CY2020Q3 dei Entity Central Index Key
EntityCentralIndexKey
0000943819
CY2020Q3 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020Q3 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q3 dei Document Type
DocumentType
10-Q
CY2020Q3 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2020Q3 dei Document Period End Date
DocumentPeriodEndDate
2020-09-30
CY2020Q3 dei Document Transition Report
DocumentTransitionReport
false
CY2020Q3 dei Entity File Number
EntityFileNumber
001-15317
CY2020Q3 dei Entity Registrant Name
EntityRegistrantName
ResMed Inc.
CY2020Q3 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2020Q3 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-0152841
CY2020Q3 dei Entity Address Address Line1
EntityAddressAddressLine1
9001 Spectrum Center Blvd.
CY2020Q3 dei Entity Address City Or Town
EntityAddressCityOrTown
San Diego
CY2020Q3 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2020Q3 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92123
CY2020Q3 dei City Area Code
CityAreaCode
858
CY2020Q3 dei Local Phone Number
LocalPhoneNumber
836-5000
CY2020Q3 dei Security12b Title
Security12bTitle
Common Stock, par value $0.004 per share
CY2020Q3 dei Trading Symbol
TradingSymbol
RMD
CY2020Q3 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2020Q3 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2020Q3 dei Entity Small Business
EntitySmallBusiness
false
CY2020Q3 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020Q3 dei Entity Shell Company
EntityShellCompany
false
CY2020Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
144915153
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
421414000
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
463156000
CY2020Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
29869000
CY2020Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
28508000
CY2020Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
464892000
CY2020Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
474643000
CY2020Q3 us-gaap Inventory Net
InventoryNet
478006000
CY2020Q2 us-gaap Inventory Net
InventoryNet
416915000
CY2020Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
178297000
CY2020Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
168745000
CY2020Q3 us-gaap Assets Current
AssetsCurrent
1542609000
CY2020Q2 us-gaap Assets Current
AssetsCurrent
1523459000
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
424819000
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
417335000
CY2020Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
124473000
CY2020Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
118348000
CY2020Q3 us-gaap Goodwill
Goodwill
1899743000
CY2020Q2 us-gaap Goodwill
Goodwill
1890324000
CY2020Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
432894000
CY2020Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
448168000
CY2020Q3 us-gaap Deferred Income Taxes And Other Assets Noncurrent
DeferredIncomeTaxesAndOtherAssetsNoncurrent
50788000
CY2020Q2 us-gaap Deferred Income Taxes And Other Assets Noncurrent
DeferredIncomeTaxesAndOtherAssetsNoncurrent
41065000
CY2020Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
145518000
CY2020Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
148677000
CY2020Q3 us-gaap Assets Noncurrent
AssetsNoncurrent
3078235000
CY2020Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
3063917000
CY2020Q3 us-gaap Assets
Assets
4620844000
CY2020Q2 us-gaap Assets
Assets
4587376000
CY2020Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
117589000
CY2020Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
135786000
CY2020Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
269859000
CY2020Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
270353000
CY2020Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
21329000
CY2020Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
21263000
CY2020Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
102035000
CY2020Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
98617000
CY2020Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
68053000
CY2020Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
64755000
CY2020Q3 us-gaap Short Term Borrowings
ShortTermBorrowings
11988000
CY2020Q2 us-gaap Short Term Borrowings
ShortTermBorrowings
11987000
CY2020Q3 us-gaap Liabilities Current
LiabilitiesCurrent
590853000
CY2020Q2 us-gaap Liabilities Current
LiabilitiesCurrent
602761000
CY2020Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
83887000
CY2020Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
87307000
CY2020Q3 us-gaap Deferred Income Taxes And Other Tax Liabilities Noncurrent
DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent
13007000
CY2020Q2 us-gaap Deferred Income Taxes And Other Tax Liabilities Noncurrent
DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent
13011000
CY2020Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
111183000
CY2020Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
101880000
CY2020Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
8568000
CY2020Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
8347000
CY2020Q3 us-gaap Long Term Debt
LongTermDebt
1044435000
CY2020Q2 us-gaap Long Term Debt
LongTermDebt
1164133000
CY2020Q3 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
90051000
CY2020Q2 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
112910000
CY2020Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1351131000
CY2020Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1487588000
CY2020Q3 us-gaap Liabilities
Liabilities
1941984000
CY2020Q2 us-gaap Liabilities
Liabilities
2090349000
CY2020Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000
CY2020Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000
CY2020Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.004
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.004
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
350000000
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
350000000
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
186744426
CY2020Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
144908192
CY2020Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
186723407
CY2020Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
144887175
CY2020Q3 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
580000
CY2020Q2 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
580000
CY2020Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1588018000
CY2020Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1570694000
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
2953709000
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
2832991000
CY2020Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
41836234
CY2020Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
41836234
CY2020Q3 us-gaap Treasury Stock Value
TreasuryStockValue
1623256000
CY2020Q2 us-gaap Treasury Stock Value
TreasuryStockValue
1623256000
CY2020Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-240191000
CY2020Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-283982000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
2678860000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
2497027000
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4620844000
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4587376000
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
751944000
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
681056000
CY2020Q3 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
301304000
CY2019Q3 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
276001000
CY2020Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
11979000
CY2019Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
13436000
CY2020Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
313283000
CY2019Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
289437000
CY2020Q3 us-gaap Gross Profit
GrossProfit
438661000
CY2019Q3 us-gaap Gross Profit
GrossProfit
391619000
CY2020Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
158989000
CY2019Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
167440000
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
54533000
CY2019Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
48033000
CY2020Q3 rmd Amortization Of Acquired Intangible Assets1
AmortizationOfAcquiredIntangibleAssets1
8243000
CY2019Q3 rmd Amortization Of Acquired Intangible Assets1
AmortizationOfAcquiredIntangibleAssets1
5044000
CY2020Q3 us-gaap Operating Expenses
OperatingExpenses
221765000
CY2019Q3 us-gaap Operating Expenses
OperatingExpenses
220517000
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
216896000
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
171102000
CY2020Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
117000
CY2019Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
449000
CY2020Q3 us-gaap Interest Expense
InterestExpense
6842000
CY2019Q3 us-gaap Interest Expense
InterestExpense
10992000
CY2020Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-2288000
CY2019Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-6863000
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
7971000
CY2019Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3109000
CY2020Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1042000
CY2019Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-20515000
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
215854000
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
150587000
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
37482000
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
30439000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
178372000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
120148000
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.23
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.84
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.22
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.83
CY2020Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.39
CY2019Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.39
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
144900000
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
143719000
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
146100000
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
145099000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
178372000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
120148000
CY2020Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
43791000
CY2019Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-37576000
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
222163000
CY2019Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
82572000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
2497027000
CY2020Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1026000
CY2020Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
227000
CY2020Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
16071000
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
43791000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
178372000
CY2020Q3 us-gaap Dividends
Dividends
56511000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
2678860000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
2072193000
CY2019Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
5609000
CY2019Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-327000
CY2019Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
13256000
CY2019Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-37576000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
120148000
CY2019Q3 us-gaap Dividends
Dividends
56052000
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
2117251000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
178372000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
120148000
CY2020Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
39466000
CY2019Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
37954000
CY2020Q3 rmd Operating Lease Right Of Use Asset Amortization
OperatingLeaseRightOfUseAssetAmortization
10422000
CY2019Q3 rmd Operating Lease Right Of Use Asset Amortization
OperatingLeaseRightOfUseAssetAmortization
5963000
CY2020Q3 us-gaap Share Based Compensation
ShareBasedCompensation
16071000
CY2019Q3 us-gaap Share Based Compensation
ShareBasedCompensation
13256000
CY2020Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-2288000
CY2019Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-6863000
CY2020Q3 us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
-8476000
CY2019Q3 us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
2590000
CY2019Q3 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-8000
CY2020Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-16110000
CY2019Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-28286000
CY2020Q3 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
52396000
CY2019Q3 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
14204000
CY2020Q3 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-3415000
CY2019Q3 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
8407000
CY2020Q3 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-61273000
CY2019Q3 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-30078000
CY2020Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
143999000
CY2019Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
162363000
CY2020Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
13501000
CY2019Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
22671000
CY2020Q3 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
5237000
CY2019Q3 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
2069000
CY2020Q3 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
8196000
CY2019Q3 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
2741000
CY2020Q3 us-gaap Payments For Proceeds From Derivative Instrument Investing Activities
PaymentsForProceedsFromDerivativeInstrumentInvestingActivities
-4824000
CY2019Q3 us-gaap Payments For Proceeds From Derivative Instrument Investing Activities
PaymentsForProceedsFromDerivativeInstrumentInvestingActivities
5743000
CY2020Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-22110000
CY2019Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-33224000
CY2020Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1026000
CY2019Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
5609000
CY2020Q3 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
227000
CY2019Q3 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
-326000
CY2019Q3 us-gaap Payments Of Merger Related Costs Financing Activities
PaymentsOfMergerRelatedCostsFinancingActivities
302000
CY2020Q3 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
55000000
CY2019Q3 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
565000000
CY2020Q3 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
175000000
CY2019Q3 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
614003000
CY2020Q3 us-gaap Payments Of Dividends
PaymentsOfDividends
56511000
CY2019Q3 us-gaap Payments Of Dividends
PaymentsOfDividends
56052000
CY2020Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-175258000
CY2019Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-100074000
CY2020Q3 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
11627000
CY2019Q3 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-4039000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-41742000
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
25026000
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
463156000
CY2019Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
147128000
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
421414000
CY2019Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
172154000
CY2020Q3 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
51370000
CY2019Q3 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
30937000
CY2020Q3 us-gaap Interest Paid Net
InterestPaidNet
6842000
CY2019Q3 us-gaap Interest Paid Net
InterestPaidNet
10992000
CY2020Q3 us-gaap Sales Type Lease Lease Income
SalesTypeLeaseLeaseIncome
1960000
CY2019Q3 us-gaap Sales Type Lease Lease Income
SalesTypeLeaseLeaseIncome
2258000
CY2020Q3 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
24779000
CY2019Q3 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
21365000
CY2020Q3 rmd Lessor Lease Revenue
LessorLeaseRevenue
26739000
CY2019Q3 rmd Lessor Lease Revenue
LessorLeaseRevenue
23623000
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
751944000
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
681056000
CY2020Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
39466000
CY2019Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
37954000
CY2020Q3 us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
2800000
CY2020Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
146976000
CY2020Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
128096000
CY2020Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
2755000
CY2020Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
2807000
CY2020Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
328275000
CY2020Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
286012000
CY2020Q3 us-gaap Inventory Net
InventoryNet
478006000
CY2020Q2 us-gaap Inventory Net
InventoryNet
416915000
CY2020Q3 us-gaap Equity Method Investments
EquityMethodInvestments
18071000
CY2020Q2 us-gaap Equity Method Investments
EquityMethodInvestments
14109000
CY2020Q3 rmd Equity Investments Total By Measurement Category
EquityInvestmentsTotalByMeasurementCategory
58526000
CY2020Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1006540000
CY2020Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
969166000
CY2020Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
581721000
CY2020Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
551831000
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
424819000
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
417335000
CY2020Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
432894000
CY2020Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
448168000
CY2020Q2 us-gaap Goodwill
Goodwill
1890324000
CY2020Q3 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
9419000
CY2020Q3 us-gaap Goodwill
Goodwill
1899743000
CY2020Q3 rmd Marketable Equity Investments Fair Value
MarketableEquityInvestmentsFairValue
19045000
CY2020Q3 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
21410000
CY2020Q2 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
30033000
CY2020Q2 rmd Equity Investments Total By Measurement Category
EquityInvestmentsTotalByMeasurementCategory
44142000
CY2020Q3 rmd Gain Loss From Change Of Accounting Methodology
GainLossFromChangeOfAccountingMethodology
8500000
CY2020Q3 us-gaap Marketable Securities Unrealized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairments
8500000
CY2019Q3 us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
2600000
CY2020Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
21132000
CY2019Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
19625000
CY2020Q3 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
5347000
CY2019Q3 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
2901000
CY2020Q3 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
3428000
CY2019Q3 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
2792000
CY2020Q3 us-gaap Standard And Extended Product Warranty Accrual Foreign Currency Translation Gain Loss
StandardAndExtendedProductWarrantyAccrualForeignCurrencyTranslationGainLoss
-640000
CY2019Q3 us-gaap Standard And Extended Product Warranty Accrual Foreign Currency Translation Gain Loss
StandardAndExtendedProductWarrantyAccrualForeignCurrencyTranslationGainLoss
572000
CY2020Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
23691000
CY2019Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
19162000
CY2020Q3 rmd Short Term Borrowings Gross
ShortTermBorrowingsGross
12000000
CY2020Q2 rmd Short Term Borrowings Gross
ShortTermBorrowingsGross
12000000
CY2020Q3 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
12000
CY2020Q2 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
13000
CY2020Q3 us-gaap Short Term Borrowings
ShortTermBorrowings
11988000
CY2020Q2 us-gaap Short Term Borrowings
ShortTermBorrowings
11987000
CY2020Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1048000000
CY2020Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1168000000
CY2020Q3 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
3565000
CY2020Q2 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
3867000
CY2020Q3 us-gaap Long Term Debt
LongTermDebt
1044435000
CY2020Q2 us-gaap Long Term Debt
LongTermDebt
1164133000
CY2020Q3 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
1056423000
CY2020Q2 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
1176120000
CY2020Q3 rmd Debt To Consolidated Ebitda Ratio
DebtToConsolidatedEbitdaRatio
3.50
CY2020Q3 us-gaap Senior Notes
SeniorNotes
500000000.0
CY2020Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
109475000
CY2019Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
693000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
178372000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
120148000
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
144900000
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
143719000
CY2020Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1200000
CY2019Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1380000
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
146100000
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
145099000
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.23
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.84
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.22
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.83

Files In Submission

Name View Source Status
0000943819-20-000024-index-headers.html Edgar Link pending
0000943819-20-000024-index.html Edgar Link pending
0000943819-20-000024.txt Edgar Link pending
0000943819-20-000024-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
rmd-20200930.xsd Edgar Link pending
rmd-20200930x10q.htm Edgar Link pending
rmd-20200930x10q_htm.xml Edgar Link completed
rmd-20200930xex31_1.htm Edgar Link pending
rmd-20200930xex31_2.htm Edgar Link pending
rmd-20200930xex32.htm Edgar Link pending
rmd-20200930_cal.xml Edgar Link unprocessable
rmd-20200930_def.xml Edgar Link unprocessable
rmd-20200930_lab.xml Edgar Link unprocessable
rmd-20200930_pre.xml Edgar Link unprocessable
Show.js Edgar Link pending